Financial and Operational Highlights:Sales decreased 27.3% to $32.2 million120.7% or $9.3 million increase in e-commerce and wholesale salesAdjusted operating loss1 […]
SAN DIEGO, July 31, 2020 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product […]
CAMBRIDGE, Mass., July 31, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]